BridgeBio Pharma, Inc. reports

Company location: Palo Alto, CA
Fiscal year end: 31 December

BridgeBio Pharma, Inc. has filed 814 SEC EDGAR filings since 19 Jun 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 701-725 of 814 matching filings.

Per page

25

Current page

29

SC 13G File 005-91059

SC 13G

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91059

SC 13G

Filing date: 14 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

5

FORM 5 SUBMISSION

Filing date: 13 Feb 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Feb 2020
Reporting date: 11 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Feb 2020
Reporting date: 10 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date: 07 Feb 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Feb 2020
Reporting date: 05 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Feb 2020
Reporting date: 03 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Feb 2020
Reporting date: 03 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Feb 2020
Reporting date: 03 Feb 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jan 2020
Reporting date: 14 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Jan 2020
Reporting date: 08 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38959

FORM 8-K

Filing date: 07 Jan 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jan 2020
Reporting date: 02 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jan 2020
Reporting date: 02 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jan 2020
Reporting date: 02 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2020
Reporting date: 01 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 03 Jan 2020
Reporting date: 01 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Dec 2019
Reporting date: 27 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38959

8-K

Filing date: 26 Dec 2019
Reporting date: 07 Nov 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38959

8-K

Filing date: 17 Dec 2019
Reporting date: 12 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Dec 2019
Reporting date: 12 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Dec 2019
Reporting date: 12 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Dec 2019
Reporting date: 12 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Dec 2019
Reporting date: 12 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .